AbbVie Total Current Liabilities vs Property Plant And Equipment Net Analysis

ABBV Stock  USD 199.50  1.01  0.50%   
AbbVie financial indicator trend analysis is way more than just evaluating AbbVie Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AbbVie Inc is a good investment. Please check the relationship between AbbVie Total Current Liabilities and its Property Plant And Equipment Net accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Total Current Liabilities vs Property Plant And Equipment Net

Total Current Liabilities vs Property Plant And Equipment Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AbbVie Inc Total Current Liabilities account and Property Plant And Equipment Net. At this time, the significance of the direction appears to have very strong relationship.
The correlation between AbbVie's Total Current Liabilities and Property Plant And Equipment Net is 0.88. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of AbbVie Inc, assuming nothing else is changed. The correlation between historical values of AbbVie's Total Current Liabilities and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of AbbVie Inc are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Total Current Liabilities i.e., AbbVie's Total Current Liabilities and Property Plant And Equipment Net go up and down completely randomly.

Correlation Coefficient

0.88
Relationship DirectionPositive 
Relationship StrengthStrong

Total Current Liabilities

Total Current Liabilities is an item on AbbVie balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of AbbVie Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most indicators from AbbVie's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AbbVie Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Sales General And Administrative To Revenue is likely to climb to 0.28 in 2024, whereas Selling General Administrative is likely to drop slightly above 7.8 B in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit38.8B40.6B45.5B25.2B
Total Revenue56.2B58.1B54.3B33.8B

AbbVie fundamental ratios Correlations

0.60.810.780.730.710.710.530.8-0.290.670.81-0.310.740.66-0.370.440.690.650.740.50.890.070.660.70.36
0.60.760.850.350.90.970.960.810.310.980.840.290.930.99-0.40.970.950.660.360.990.750.660.970.950.94
0.810.760.970.310.940.80.670.970.190.740.960.170.830.78-0.40.70.830.580.360.740.950.510.710.80.66
0.780.850.970.30.970.880.790.970.220.840.960.20.870.86-0.440.80.870.620.340.840.930.550.810.870.76
0.730.350.310.30.260.480.290.26-0.520.460.42-0.550.460.4-0.260.140.40.610.980.190.47-0.240.480.470.07
0.710.90.940.970.260.870.840.960.290.870.930.270.860.9-0.40.870.880.660.280.890.880.620.850.860.84
0.710.970.80.880.480.870.920.810.150.980.890.130.960.98-0.440.890.960.680.520.930.810.530.960.990.84
0.530.960.670.790.290.840.920.740.190.970.770.170.840.96-0.280.950.870.570.310.950.640.520.980.890.93
0.80.810.970.970.260.960.810.740.220.790.930.20.850.83-0.430.760.860.580.30.80.940.540.760.810.73
-0.290.310.190.22-0.520.290.150.190.220.130.171.00.170.19-0.280.460.22-0.05-0.510.420.10.910.10.160.53
0.670.980.740.840.460.870.980.970.790.130.840.110.920.99-0.360.930.940.690.470.950.750.51.00.960.88
0.810.840.960.960.420.930.890.770.930.170.840.150.880.85-0.460.770.880.590.480.810.920.510.820.880.74
-0.310.290.170.2-0.550.270.130.170.21.00.110.150.150.17-0.220.450.2-0.07-0.540.40.080.90.080.130.51
0.740.930.830.870.460.860.960.840.850.170.920.880.150.95-0.390.850.980.660.480.890.870.560.90.970.78
0.660.990.780.860.40.90.980.960.830.190.990.850.170.95-0.380.940.970.680.420.970.780.570.980.970.89
-0.37-0.4-0.4-0.44-0.26-0.4-0.44-0.28-0.43-0.28-0.36-0.46-0.22-0.39-0.38-0.35-0.42-0.29-0.29-0.37-0.41-0.36-0.35-0.43-0.33
0.440.970.70.80.140.870.890.950.760.460.930.770.450.850.94-0.350.890.550.160.990.650.750.920.870.99
0.690.950.830.870.40.880.960.870.860.220.940.880.20.980.97-0.420.890.640.440.930.820.590.910.980.83
0.650.660.580.620.610.660.680.570.58-0.050.690.59-0.070.660.68-0.290.550.640.570.590.650.290.680.690.46
0.740.360.360.340.980.280.520.310.3-0.510.470.48-0.540.480.42-0.290.160.440.570.210.49-0.220.490.520.08
0.50.990.740.840.190.890.930.950.80.420.950.810.40.890.97-0.370.990.930.590.210.70.730.930.920.97
0.890.750.950.930.470.880.810.640.940.10.750.920.080.870.78-0.410.650.820.650.490.70.450.720.810.59
0.070.660.510.55-0.240.620.530.520.540.910.50.510.90.560.57-0.360.750.590.29-0.220.730.450.470.540.77
0.660.970.710.810.480.850.960.980.760.11.00.820.080.90.98-0.350.920.910.680.490.930.720.470.940.88
0.70.950.80.870.470.860.990.890.810.160.960.880.130.970.97-0.430.870.980.690.520.920.810.540.940.82
0.360.940.660.760.070.840.840.930.730.530.880.740.510.780.89-0.330.990.830.460.080.970.590.770.880.82
Click cells to compare fundamentals

AbbVie Account Relationship Matchups

AbbVie fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding1.5B1.7B1.8B1.8B1.8B1.8B
Total Assets89.1B150.6B146.5B138.8B134.7B81.2B
Other Current Liab10.4B17.9B19.8B22.5B30.7B32.2B
Total Current Liabilities15.6B28.7B35.2B29.5B37.8B39.7B
Total Stockholder Equity(8.2B)13.1B15.4B17.3B10.4B7.1B
Other Liab18.5B30.4B31.0B31.7B36.5B38.3B
Property Plant And Equipment Net3.0B5.2B5.1B4.9B5.0B3.6B
Net Debt26.8B77.6B66.9B54.1B46.6B32.2B
Accounts Payable1.5B2.3B2.9B2.9B3.7B3.9B
Cash39.9B8.4B9.7B9.2B12.8B10.5B
Non Current Assets Total39.6B126.4B118.6B110.3B101.7B57.7B
Other Assets1.9B5.1B4.1B4.8B5.6B5.8B
Cash And Short Term Investments39.9B8.5B9.8B9.2B12.8B11.0B
Net Receivables5.4B8.8B10.0B11.3B11.2B6.8B
Good Will15.6B33.1B32.4B32.2B32.3B18.6B
Short Term Investments0.030M84M28M2M1.9M
Liabilities And Stockholders Equity89.1B150.6B146.5B138.8B134.7B81.2B
Non Current Liabilities Total81.7B108.8B95.9B92.0B86.5B55.5B
Inventory1.8B3.3B3.1B3.6B4.1B2.2B
Other Stockholder Equity(9.3B)15.1B15.2B14.7B13.6B7.1B
Total Liab97.3B137.5B131.1B121.5B124.3B74.1B
Property Plant And Equipment Gross3.0B5.2B10.7B11.0B11.6B12.2B
Total Current Assets49.5B24.2B27.9B28.5B33.0B23.5B
Accumulated Other Comprehensive Income(3.6B)(3.1B)(2.9B)(2.2B)(2.3B)(2.4B)
Intangible Assets18.6B82.9B76.0B67.4B55.6B32.2B
Property Plant Equipment3.0B5.2B5.1B4.9B5.7B3.4B
Long Term Debt63.0B77.6B64.2B59.1B52.2B41.2B
Short Long Term Debt Total66.7B86.1B76.7B63.3B59.4B49.8B
Non Currrent Assets Other1.2B1.2B1.9B3.4B6.6B6.9B
Short Term Debt3.8B8.5B12.5B4.1B7.2B5.2B
Net Tangible Assets(42.4B)(102.9B)(96.2B)(82.3B)(74.1B)(77.8B)
Retained Earnings4.7B1.1B3.1B4.8B(1B)(950M)
Retained Earnings Total Equity4.7B1.1B3.1B4.8B5.5B3.4B
Long Term Debt Total63.0B77.6B64.2B59.1B68.0B50.1B
Capital Surpluse15.2B17.4B18.3B19.2B22.1B15.8B
Additional Paid In Capital15.2B17.4B18.3B19.2B20.2B15.0B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.